G. Bradley Cole, CFO at GENOMIC HEALTH INC (GHDX), sold 84,462 shares at $72.10 ($6.1M) on 2019-09-09, disclosed to the SEC on 2019-09-11.
Seasonal sale ($6.1M) by CFO — this insider has traded GHDX in September in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.10 | 17,531 | $1.3M | 20.7% |
| 2 | $72.10 | 17,531 | $1.3M | 20.7% |
| 3 | $73.35 | 5,707 | $419K | 6.9% |
| 4 | $73.35 | 5,707 | $419K | 6.9% |
| 5 | $74.00 | 1,762 | $130K | 2.1% |
| 6 | $71.59 | 13,303 |
| $952K |
| 15.6% |
| 7 | $71.60 | 13,303 | $952K | 15.6% |
| 8 | $72.33 | 4,809 | $348K | 5.7% |
| 9 | $72.33 | 4,809 | $348K | 5.7% |
| Total | $72.18 avg | 84,462 | $6.1M | 100% |
| Filing → |
| EXAS | SELL | 2020-02-21 | $2.7M | — | Filing → |
| EXAS | SELL | 2020-01-17 | $903K | — | Filing → |
| EXAS | SELL | 2019-11-25 | $4.5M | — | Filing → |